It has been reported that LEMD1 is aberrantly overexpressed in a series of malignancies and is correlated with worse prognosis of tumor patients such as prostate cancer, colorectal cancer, gastric cancer and pancreatic cancer [5,6,7,8,9]. This evidence concerns the gene LEMD1 and pancreatic neoplasm.